AlphaQuest’s Praxis Precision Medicines PRAX Stock Holding History

AlphaQuest’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,075	Closed	-$317K	–	1548
2025 Q4	$317K	Sell	1,075 -924	-46%	-$172K	0.02%	1169
2025 Q3	$106K	Buy	1,999 +1,883	+1,623%	+$91.3K	0.01%	1706
2025 Q2	$4.88K	Sell	116 -32	-22%	-$1.22K	﹤0.01%	1888
2025 Q1	$5.61K	Buy	148 +53	+56%	+$3.31K	﹤0.01%	1849
2024 Q4	$7.31K	Buy	+95	New	+$6.87K	﹤0.01%	1522
2024 Q2	–	Sell	-109	Closed	-$6.65K	–	1819
2024 Q1	$6.65K	Buy	+109	New	+$4.89K	﹤0.01%	1092

Other funds holding PRAX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

AlphaQuest's PRAX Position: Q1 2026 in Review

AlphaQuest sold out of Praxis Precision Medicines (PRAX) in Q1 2026, closing a stake of 1,075 shares — an estimated $317K sold.

AlphaQuest first reported a position in PRAX in Q1 2024 and held it in 6 quarters. The position peaked at $317K in Q4 2025. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

AlphaQuest reported no remaining Praxis Precision Medicines position as of Q1 2026 after selling out during the quarter.
AlphaQuest sold 1,075 Praxis Precision Medicines shares in Q1 2026, an estimated $317K.
AlphaQuest first reported a position in Praxis Precision Medicines in Q1 2024 and held it in 6 quarters.
AlphaQuest's Praxis Precision Medicines position peaked at $317K in Q4 2025.
289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.